Parkinson’s Disease: Advice for Community Neurologists
Expert neurologists provide insight on how to decide on an on-demand therapy for Parkinson’s disease and provide some general advice.
Realistic Outlook for Mesenchymal Stem Cells, Other Treatments in Progressive MS: Jeffrey Cohen, MD
November 22nd 2021The director of the Mellen Center for MS Treatment and Research at Cleveland Clinic discussed when clinicians should anticipate new therapies to treat progressive MS. [WATCH TIME: 2 minutes]
Next Steps, Future Development of FUS Technology in Alzheimer Disease: Ali Rezai, MD
November 22nd 2021The executive chair of the Rockefeller Neuroscience Institute at West Virginia University discussed the potential of focused ultrasound for patients with AD, as well as key takeaways for clinicians from a recent study. [WATCH TIME: 5 minutes]
AUPN Leadership Minute Episode 16: Turning Your Clinic Into a Source of Scholarly Activity
November 20th 2021Episode 16 of the AUPN Leadership Minute features Rohit Das, MD, of UT Southwestern Medical Center; and Selim R. Benbadis, MD, FAAN, FACNS, FAES, University of South Florida Morsani College of Medicine. [WATCH TIME: 4 minutes]
Migraine: A Historic Perspective on Preventative Therapy
Andrew C. Charles, MD, provides a historical perspective on the agents traditionally used for preventive migraine therapy.
Pitolisant for Narcolepsy and EDS: FDA Approval and Personal Experience
November 19th 2021Expert neurologist and sleep specialist Chris Winter, MD, discusses the FDA approval of pitolisant for patients with narcolepsy and excessive daytime sleepiness in the context of his own experience with this novel agent.
Heart Rate Variability’s Role in Potential SUDEP-Predicting Modalities: Orrin Devinsky, MD
November 19th 2021The director of the Comprehensive Epilepsy Center at NYU Langone provided insight on whether a newly discovered biomarker can play a role in the creation of modalities to detect SUDEP risk. [WATCH TIME: 3 minutes]
Incorporation of Registered Dietitians in MS Care: Tyler Titcomb, PhD, RDN, IFMCP
November 18th 2021The postdoctoral scholar at the University of Iowa commented on why the multiple sclerosis field should lean on registered dietitians to help alleviate symptoms of patients with multiple sclerosis. [WATCH TIME: 2 minutes]
Therapeutic Approaches to Fatigue in Multiple Sclerosis: Anna Kratz, PhD
November 17th 2021Discussing cognitive behavioral therapy for patients with MS, the associate professor of Physical Medicine and Rehabilitation and research nonclinical psychologist at the University of Michigan Medicine mentioned different therapeutic options that can benefit this patient population. [WATCH TIME: 3 minutes]
Why MS Clinicians Should Care More Abo ut Diet: Tyler Titcomb, PhD, RDN, IFMCP
November 17th 2021The postdoctoral scholar at the University of Iowa discussed the importance of understanding more about the effects of diet and how it is managed when caring for a patient with multiple sclerosis. [WATCH TIME 3 minutes]
Strategies, Tools for Treating Fatigue in Multiple Sclerosis: Anna Kratz, PhD
November 16th 2021The associate professor of Physical Medicine & Rehabilitation and research nonclinical psychologist at the University of Michigan Medicine discussed challenges when addressing fatigue, as well as the need to integrate digital tools for patients with MS. [WATCH TIME: 4 minutes]
Side Effects of Apomorphine Usage in Parkinson’s Disease
A panel of experts debate the disadvantages and side effects of apomorphine therapies for Parkinson’s disease.